跳至主要内容
临床试验/NCT01255670
NCT01255670已完成不适用

Penicillin and Metronidazole in Treatment of Peritonsillar Abscess - Prospective, Double-blind, Randomized, Placebo-controlled Study

Helsinki University Central Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2010年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Number of Participants With Recurrence of Peritonsillar Abscess

研究概览

简要总结

Treatment of peritonsillar abscess varies. To study whether broad spectrum antibiotics are required in addition to abscess drainage, a prospective, double blind, placebo-controlled, randomized study on 200 adult patients with peritonsillar abscess is performed. 100 patients are given penicillin and metronidazole and 100 patients get penicillin and placebo. Recovery and recurrence are analyzed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • referring doctor suspects peritonsillar abscess
  • patient is voluntary
  • patient has daily access to his/her e-mail
  • patient speaks and understands Finnish of Swedish
  • female patients have adequate birth-control method
  • patient has peritonsillar abscess

排除标准

  • allergy to penicillin
  • allergy to metronidazole
  • use of metronidazole in preceding one month
  • pregnancy
  • breast-feeding
  • renal insufficiency
  • liver insufficiency
  • alcoholism (drunk at least once a week)
  • participant in another clinical trial at the moment
  • treatment of peritonsillar abscess requires in-patient care
  • tonsillectomy during the next 30 days
  • army recruit

研究组 & 干预措施

penicillin and metronidazole

Active Comparator

After incision and drainage 100 randomized patients receive penicillin and metronidazole as treatment of peritonsillar abscess

干预措施: penicillin and metronidazole in peritonsillar abscess (Drug)

penicillin and placebo

Placebo Comparator

After incision and drainage 100 randomized patients receive penicillin and placebo as treatment of peritonsillar abscess

干预措施: penicillin and metronidazole in peritonsillar abscess (Drug)

结局指标

主要结局

Number of Participants With Recurrence of Peritonsillar Abscess

时间窗: 56 days

Number of participants with recurrence of peritonsillar abscess having metronidazole in addition to penicillin or penicillin and placebo.

次要结局

  • Number of Participants Recovering From Peritonsillar Abscess(28 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karin Blomgren

Senior Medical Officer in Charge of Research

Helsinki University Central Hospital

研究点 (1)

Loading locations...

相似试验